Ronald M. Krauss, MD
Director, Atherosclerosis Research
Children's Hospital
Oakland Research Institute
Cholesterol Research Center
Oakland, California
Ronald M. Krauss, MD, is Senior Scientist and Director of Atherosclerosis Research at Children's Hospital Oakland Research Institute, Guest Senior Scientist in the Genome Sciences Division at the Lawrence Berkeley National Laboratory, and Adjunct Professor, Department of Nutritional Sciences, University of California at Berkeley.
Dr Krauss received his medical degree with honors from Harvard University and served his internship and residency on the Harvard Medical Service of Boston City Hospital.
His research involves studies of genetic, dietary, and pharmacologic effects on plasma lipoproteins and coronary artery disease risk. He is a member of the American Society for Clinical Investigation, the American Federation for Clinical Research, and the Federation of American Societies for Experimental Biology. Dr Krauss served as Senior Advisor to the National Cholesterol Education Program, and was a member of the Macronutrient Panel of the Dietary Reference Intake Committee of the Institute of Medicine, National Academy of Sciences. He was Chair of the American Heart Association (AHA) Nutrition Committee and of the Research Committee of the AHA Western States Affiliate, and is currently a member of the AHA National Board of Directors as well as the National Spokespersons Panel. He is also founder and immediate past Chair of the AHA Council on Nutrition, Physical Activity, and Metabolism.
Dr Krauss has received the AHA Scientific Councils Distinguished Achievement Award, and the Special Recognition Award from the AHA Council on Arteriosclerosis, Thrombosis, and Vascular Biology. Dr Krauss has been a member of the editorial boards of several journals, including the American Journal of Clinical Nutrition, Vascular Pharmacology, and Preventive Cardiology, and has been Associate Editor of the Journal of Lipid Research. He has published more than 300 research articles and reviews and is currently Principal Investigator of two large research programs: "Institute for Genetics and Nutrition" and "Pharmacogenetics and Risk of Cardiovascular Disease."






